Hmmm, the decline in death rate in Sao Paulo is VERY interesting weasel, especially given the timing with the start of the Leronlimab critical trial. Thanks for sharing it. Is the overall new case rate declining as well in Sao Paulo, or has that stayed steady or increased? If the case count is going down, then perhaps that would indicate vaccines may be helping, but if the new cases are still going up or are steady, then something is going on, either more success with some sort of therapeutic, or a change in reporting? I'm intrigued. Will be interesting to keep following the data.